Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel CLDN18.2-targeted 4-1BB bispecific antibody with potent antitumor activity

July 9, 2020

Preclinical data presented for anti-CD33 JNJ-67571244 in AML

July 9, 2020

Phase I study of DWP-710 approved in Indonesia

July 9, 2020

Antitoxin vaccine fights S. aureus

July 9, 2020

Calpain-2 in common, rare neurodegeneration

July 9, 2020

Hepion reports promising preclinical data with CRV-431 supporting potential for COVID-19

July 8, 2020

Corvus begins phase I study of CPI-006 in COVID-19

July 8, 2020

STK-001 studied for Dravet syndrome in new phase I/II study

July 8, 2020

GSK and Medicago collaborate on adjuvanted COVID-19 candidate vaccine

July 8, 2020

InMed begins second phase I trial of INM-755 for epidermolysis bullosa

July 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...